CP 4126: Clinical Trials

3 trials of CP 4126, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Completed 1

Follow CP 4126: new trials by email Literature Review of CP 4126 trials Research Report on CP 4126

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin
CO-1.01 and Cisplatin - Solid Tumor, Non-small-cell Lung Cancer
Phase 1TerminatedClovis Oncology, Inc.82012-07-012014-03-11
A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
IV CP-4126 - Advanced Adenocarcinoma of Pancreas
Phase 2CompletedClavis Pharma212009-04-012012-02-10
A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour
CP-4126, Gemcitabine - Solid Tumors
Phase 1CompletedClavis Pharma262008-10-012010-09-06

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Sponsors

Clavis Pharma (2)  ·  Clovis Oncology, Inc. (1)

Countries

Belgium (2)  ·  Netherlands (1)  ·  Norway (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ahmad H Awada, MD (1)

Results publications

PMID 23345000